Author Archives: admin


Stem Cell Clinic > Articles by: admin

Blood cells from Embryonic Stem Cells: Cornelis Murre – CIRM Science Writer’s Seminar – Video

By Uncategorized

(Part 2 of 9) Cornelis Murre, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Murre has a CIRM grant to develop an approach that would allow large-scale production of blood cells from human embryonic cells.

Continue reading here:
Blood cells from Embryonic Stem Cells: Cornelis Murre - CIRM Science Writer's Seminar - Video

Human Embryonic Stem Cells for Predictive Toxicology – Video

By Uncategorized

(Part 3 of 4) Michael McMaster, PhD, spoke at a seminar about stem cell research and environmental health held on September 30, 2009 at the California Institute for Regenerative Medicine. McMaster summarized the challenges of predictive toxicology and described how he has applied human embryonic stem cells as a model system for studying the toxicological effects of nicotine. A similar approach could be used to assess the role of chemicals in the development of autism

Read this article:
Human Embryonic Stem Cells for Predictive Toxicology - Video

Stem Cell Based Therapies for Blindness: David Hinton – CIRM Science Writer’s Seminar – Video

By Uncategorized

(Part 6 of 9) David Hinton, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Hinton has a CIRM grant to study the therapeutic potential of retinal pigment epithelial cell lines derived from human embryonic stem cells for retinal degeneration. Hinton is a professor of pathology, neurosurgery, and ophthalmology at the Keck School of Medicine at the University of Southern California.

View post:
Stem Cell Based Therapies for Blindness: David Hinton - CIRM Science Writer's Seminar - Video

Stem Cell Based Diabetes Treatment: Alan Lewis – CIRM Science Writer’s Seminar – Video

By Stem Cell Treatment

(Part 5 of 9) Alan Lewis, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis was president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes.

See the original post:
Stem Cell Based Diabetes Treatment: Alan Lewis - CIRM Science Writer's Seminar - Video

Getting Stem Cell Therapies Approved: Ann Tsukamoto – CIRM Science Writer’s Seminar – Video

By Stem Cell Treatment

(Part 7 of 9) Ann Tsukamoto, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Tsukamoto is the Chief Operating Officer at Stem Cells, Inc., a Palo Alto based company that has begun a stem cell based human clinical trial for the treatment of Batten disease. Tsukamoto reviewed the process of getting the therapy approved for the clinical trial.

The rest is here:
Getting Stem Cell Therapies Approved: Ann Tsukamoto - CIRM Science Writer's Seminar - Video

Fat-Derived Stem Cells for Tissue Repair: Michael Longaker – CIRM Science Writer’s Seminar – Video

By Uncategorized

(Part 4 of 9) Michael Longaker, MD, spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Longaker has a CIRM grant to derive and analyze pluripotent disease specific stem cells that will provide a better understanding of cardiovascular and bone disease. Longaker is a Deane P.

Read more:
Fat-Derived Stem Cells for Tissue Repair: Michael Longaker - CIRM Science Writer's Seminar - Video

Austin Forum – Nov 1st (Highlights) – Video

By Uncategorized

Stem Cell Therapy in the Treatment of Patients with Ischemic Heart Failure Emerson Perin, MD, PhD., Director, Clinical Research for Cardiovascular Medicine and the Medical Director of the Stem Cell Center, Texas Heart Institute, St. Luke's Episcopal Hospital Scientific advancements in the stem cell field can lead to new treatments and therapies for diseases and medical disorders for which we have few or no effective medications or treatment options.

See the rest here:
Austin Forum - Nov 1st (Highlights) - Video

→←